Loss of Transcription Factor Nuclear Factor-Erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Leads to Dysregulation of Immune Functions, Redox Homeostasis, and Intracellular Signaling in Dendritic CellsHan Xian Aw Yeang, Jean G. Sathish|Journal of Biological Chemistry|2012Cited by 91
Nuclear Factor-erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Modulates Dendritic Cell Immune Function through Regulation of p38 MAPK-cAMP-responsive Element Binding Protein/Activating Transcription Factor 1 SignalingLaith M Abbas Al-Huseini, Jean G. Sathish|Journal of Biological Chemistry|2013Cited by 54
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studiesFrank R. Brennan, David P. Humphreys, Derrick R. Witcher et al.|mAbs|2025Cited by 30
Beyond MABEL: An Integrative Approach to First in Human Dose Selection of Immunomodulators by the Health and Environmental Sciences Institute (HESI) Immuno‐Safety Technical Committee (ITC)Mineo Matsumoto, Jean G. Sathish, Joseph Ryan Polli et al.|Clinical Pharmacology & Therapeutics|2024Cited by 15
Abstract LB-B33: Nonclinical safety evaluation of two distinct second generation variants of anti-CTLA4 monoclonal antibody, ipilimumab, in monkeysKaren Price, Michael J. Graziano, Frank Simutis et al.|Molecular Cancer Therapeutics|2018Cited by 11